Chromosomal translocations of the KMT2A/MLL gene are frequently diagnosed in acute leukemia patients (ALL and AML) with very poor outcome. Here, we used the CRISPR/Cas9 technology to model this translocation t(4;11)(q21;q23) in hematopoietic stem cells deriving from umbilical cord blood.
